Cloning of human bone morphogenetic protein type IB receptor (BMPR-IB) and its expression in prostate cancer in comparison with other BMPRs

被引:51
|
作者
Ide, H
Katoh, M
Sasaki, H
Yoshida, T
Aoki, K
Nawa, Y
Osada, Y
Sugimura, T
Terada, M
机构
[1] NATL CANC CTR,RES INST,DIV GENET,CHUO KU,TOKYO 104,JAPAN
[2] MIYAZAKI MED COLL,DEPT PARASITOL,MIYAZAKI 88916,JAPAN
[3] MIYAZAKI MED COLL,DEPT UROL,MIYAZAKI 88916,JAPAN
关键词
bone morphogenetic protein receptor; prostate cancer; human BMPR-IB;
D O I
10.1038/sj.onc.1200964
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bone metastasis is a common event in prostate cancer, and it is known that some of the bone morphogenetic proteins (BMPs) are expressed in prostate cancer cells, while no study on the expression of their receptors, BMPRs, has been reported, Here we report cloning and sequence analysis of the human BMPR-IB cDNA. We also analysed the expression of transcripts of three types of the BMPR genes in human tissues and prostate cancer cell lines, The BMPR-IB mRNA was present in various organs, but the highest level was found in the prostate. Moreover, the amount of BMPR-IB mRNA was significantly low in prostate cancer tissues after androgen withdrawal and was also low in prostate cancer cell lines. RT-PCR analysis showed that the BMPR-IB message was upregulated by androgen stimulation in the LNCaP cell line which expresses the androgen receptor, By contrast, the mRNA levels of BMPR-IA and BMPR-II were not significantly different among non-cancerous and cancerous prostate tissues. It was also suggested that human BMPR-IA and BMPR-IB might have different biological functions in the prostate, although their sequences were 85.3% identical in the serine-threonine kinase domain.
引用
收藏
页码:1377 / 1382
页数:6
相关论文
共 50 条
  • [41] Signaling by growth/differentiation factor 5 through the bone morphogenetic protein receptor type IB protects neurons against kainic acid-induced neurodegeneration
    Zhao, Yuanzheng
    Zhang, Min
    Liu, Hengfang
    Wang, Jianping
    NEUROSCIENCE LETTERS, 2017, 651 : 36 - 42
  • [42] Expression of dominant-negative bone morphogenetic proteins receptor type II in the human prostate cancer cell line, PC3
    Kim, IY
    Kim, SJ
    Morton, RA
    JOURNAL OF UROLOGY, 2003, 169 (04): : 215 - 215
  • [43] The expression of bone morphogenetic protein7 and its receptors in the human normal kidney and kidney cancer
    Bobinac, D.
    Maric, I.
    Markic, D.
    Cvijanovic, O.
    Spanjol, J.
    Celic, T.
    Fuckar, Z.
    CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S61 - S61
  • [44] Bone morphogenetic protein 4 (BMP4) and its receptor BMPR1A in human adipose tissue and its regulation by insulin and free fatty acids
    Dobrzycka, M.
    Stefanowicz, M.
    Matulewicz, N.
    Nikolajuk, A.
    Dadan, J.
    Mysliwiec, P.
    Kowalska, I.
    Karczewska-Kupczewska, M.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S261 - S262
  • [45] Mutation in the type IB bone morphogenetic protein receptor alk6b impairs germ-cell differentiation and causes germ-cell tumors in zebrafish
    Neumann, Joanie C.
    Chandler, Garvin L.
    Damoulis, Vanessa A.
    Fustino, Nicholas J.
    Lillard, Katherine
    Looijenga, Leendert
    Margraf, Linda
    Rakheja, Dinesh
    Amatruda, James F.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (32) : 13153 - 13158
  • [46] Assessment of structurally and functionally high-risk nsSNPs impacts on human bone morphogenetic protein receptor type IA (BMPR1A) by computational approach
    Islam, Md. Jahirul
    Parves, Md. Rimon
    Mahmud, Shafi
    Tithi, Fahmida Alam
    Abu Reza, Md.
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2019, 80 : 31 - 45
  • [47] Expression of parathyroid hormone-related protein and its receptor in bone metastases from prostate cancer
    Iddon, J
    Bundred, NJ
    Hoyland, J
    Downey, SE
    Baird, P
    Salter, D
    McMahon, R
    Freemont, AJ
    JOURNAL OF PATHOLOGY, 2000, 191 (02): : 170 - 174
  • [48] Overexpression of a dominant negative type II bone morphogenetic protein receptor inhibits the growth of human breast cancer cells
    Pouliot, F
    Blais, A
    Labrie, C
    CANCER RESEARCH, 2003, 63 (02) : 277 - 281
  • [49] Knockdown of Bone Morphogenetic Proteins Type 1a Receptor (BMPR1a) in Breast Cancer Cells Protects Bone from Breast Cancer-Induced Osteolysis by Suppressing RANKL Expression
    Liu, Yang
    Zhang, Ran-Xi
    Yuan, Wei
    Chen, Hou-Qing
    Tian, Dong-Dong
    Li, Hao
    Jiang, Xiao
    Deng, Zhong-Liang
    Wang, Yang
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 45 (05) : 1759 - 1771
  • [50] Immunolocalization and messenger RNA expression of Bone Morphogenetic Protein-4 (BMP-4) in human prostate cancer progression.
    Thomas, R
    Roudier, MP
    Brubaker, KD
    Vessella, RL
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S567 - S567